Latest AI and machine learning research in ovarian cancer for healthcare professionals.
Homologous recombination deficiency (HRD) is a critical biomarker in high-grade serous ovarian cancer for the clinical benefit from platinum-based chemotherapy and poly polymerase inhibitors, but molecular testing is costly, time-consuming, and limited by tissue requirements. In this study, we introduce dPathHRD (digital Pathological assessment of Homologous Recombination Deficiency), a deep learn...
We present a framework for data-efficient training of machine-learning interatomic potentials for interfacial chemistry, especially heterogeneous catalytic systems. We establish strategies for density functional theory training data generation consisting of procedurally generated bulk, surface, and gas-phase atomic geometries, as well as moderately randomized structures. We show how ensembles of n...
BACKGROUND: Breast cancer (BC) is the most common malignancy afflicting women worldwide, yet the role of relaxin-related genes (RLN) in BC progression...
BACKGROUND & AIMS: Alcohol abstinence enables hepatic recompensation in patients with decompensated alcohol-related cirrhosis. This study investigated...
Bone metastasis is a major cause of morbidity and mortality in breast cancer, yet effective prognostic models and targeted therapies remain limited. H...
The rapid development of deep learning-based computational pathology and genomics has demonstrated the significant promise of effectively integrating ...
This study utilized a novel Proximity Barcoding Assay to perform high-resolution proteomic profiling of individual plasma extracellular vesicles from ...
Serous effusions, including pleural effusion and ascites, commonly occur in advanced cancers like lung and ovarian carcinomas. Detecting tumor cells i...
Heavy and essential metals coexist in a cell, collectively participate in cellular biological processes, and lead to overall health consequences. Howe...
Breast cancer presents substantial molecular heterogeneity, requiring accurate subtype classification, receptor-status prediction, and survival estima...
Transcriptomic assays such as the PAM50-based ROR-P score guide recurrence risk stratification in non-metastatic, ER-positive, HER2-negative breast ca...
RATIONALE AND OBJECTIVES: This study evaluates the accuracy of the nn-UNet TotalSegmentator (TS) by Wasserthal et al. (2023) in segmenting atypical li...
BACKGROUND: Approximately half of all high-grade serous ovarian carcinomas (HGSCs) have a therapeutically targetable defect in homologous recombinatio...
BACKGROUND: Metastasis drives mortality in breast invasive carcinoma. We sought miRNA biomarkers that (i) discriminate metastatic potential, (ii) stra...
OBJECTIVE: The Focused Assessment with Sonography for Trauma (FAST) enables rapid detection of free intraperitoneal fluid, facilitating timely managem...
BACKGROUND: Clinical practice currently lacks objective and accurate screening tools for minimal hepatic encephalopathy (MHE). Therefore, we aimed to ...
Emerging evidence highlights RNA N6-methyladenosine (m6A) modifications as pivotal regulators of tumorigenesis, yet the synergistic roles of m6A reade...
Celecoxib (CXB) is a non-steroidal anti-inflammatory drug used to prevent and treat arthritis. However, overdosing or improper use can cause adverse r...
Supported platinum catalysts are widely used in industry for hydrogenation reactions. The variations of the electronic and geometric properties of Pt ...
INTRODUCTION: This study aimed to create a survival prediction model for breast cancer(BC) using perioperative anesthesia - related drug target genes(...